Iron metabolism and metabolic dysfunction-associated fatty liver disease
References
- Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202–9.
- Segura-Azuara N de los Á, Varela-Chinchilla CD, Trinidad-Calderón PA. MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis. Front Med (Lausanne) .2022; 8. Available from: https://pubmed.ncbi.nlm.nih.gov/35096868/.
- Carnagarin R, Tan K, Adams L, et al. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-A Condition Associated with Heightened Sympathetic Activation. Int J Mol Sci. 2021; 22(8). Available from: https://pubmed.ncbi.nlm.nih.gov/33921881/.
- Datz C, Müller E, Aigner E. Iron overload and non-alcoholic fatty liver disease. Minerva Endocrinol. 2017;42(2):173–83.
- Feng G, Byrne CD, Targher G, Wang F, Zheng MH. Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link? Liver Int. 2022;42(7):1496–502.
- Deugnier Y, Bardou-Jacquet É, Lainé F. Dysmetabolic iron overload syndrome (DIOS). Presse Med. 2017;46(12 Pt 2):e306–11.
- Kowdley K V., Belt P, Wilson LA, et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2012;55(1):77–85.
- Ryan JD, Armitage AE, Cobbold JF, et al. Hepatic iron is the major determinant of serum ferritin in NAFLD patients. Liver Int. 2018;38(1):164–73.
- Yan JX, Pan BJ, Zhao PP, Wang LT, Liu JF, Fu SB. Serum ferritin is correlated with non-alcoholic fatty liver disease in middle-aged and older patients with type 2 diabetes. Endocr Connect. 2021;10(12):1560.
- Shah RA, Kowdley K V. Serum ferritin as a biomarker for NAFLD: ready for prime time? Hepatol Int. 2019;13(2):110–2.
- Moris W, Verhaegh P, Jonkers D, Deursen C Van, Koek G. Hyperferritinemia in Nonalcoholic Fatty Liver Disease: Iron Accumulation or Inflammation? Semin Liver Dis. 2019;39(4):476–82.
- Ellervik C, Mandrup-Poulsen T, Andersen HU, et al. Elevated transferrin saturation and risk of diabetes: three population-based studies. Diabetes Care. 2011;34(10):2256–8.
- Yang HH, Chen GC, Li DM, et al. Serum iron and risk of nonalcoholic fatty liver disease and advanced hepatic fibrosis in US adults. Sci Rep. 2021; 11(1). Available from: https://pubmed.ncbi.nlm.nih.gov/34002001/.
Language: English
Page range: 182 - 186
Submitted on: Jun 5, 2023
Accepted on: Aug 15, 2023
Published on: Sep 28, 2023
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2023 Zoltán-Zsombor Élthes, Monica Iudita Maria Szabó, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.